Clinical Trials Browser

Phase 2 × Breast Cancer Invasive × 1 year × Clear all

NCT03627988 2026-05-22

MARTA

Phase 2 Completed

Breast Cancer Invasive

NCT06695039 2025-12-02

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

Phase 2 Completed

Breast Cancer Invasive